
    
      At the Baseline Visit (Day 1) and after completion of all evaluations, each subject who
      qualifies for entry will will receive a dose of 0.5 g IMP on the back of a hand affected with
      skin atrophy.

      PK-samples will be withdrawn at 0, 2, 4, 6, 24, 48 and 72 hours.
    
  